Veracyte’s (VCYT) “Buy” Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed their buy rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a report issued on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $51.00 target price on the biotechnology company’s stock. Several other analysts also recently commented on VCYT. StockNews.com downgraded shares of Veracyte from a “buy” […]
Needham & Company LLC reaffirmed their buy rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a report issued on Tuesday morning,Benzinga reports. Needham & Company LLC currently has a $51.00 target price on the biotechnology company’s stock. Several other analysts also recently commented on VCYT. StockNews.com downgraded shares of Veracyte from a “buy” […]
